Download Zipped Enrolled WordPerfect HB0258.ZIP
[Introduced][Amended][Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 258 Enrolled






Chief Sponsor: Rebecca D. Lockhart

Senate Sponsor: Curtis S. Bramble

             8      LONG TITLE
             9      General Description:
             10          This bill amends the Medical Assistance Act.
             11      Highlighted Provisions:
             12          This bill:
             13          .    prohibits the inclusion of immunosuppressive drugs used to prevent transplanted
             14      organ rejection:
             15              .    on a preferred drug list for the State Medicaid Program;
             16              .    in step therapy requirements of the Drug Utilization Board; and
             17              .    in generic substitution requirements of the State Medicaid Program.
             18      Monies Appropriated in this Bill:
             19          None
             20      Other Special Clauses:
             21          None
             22      Utah Code Sections Affected:
             23      AMENDS:
             24          26-18-2.4, as last amended by Laws of Utah 2007, Chapter 385
             26      Be it enacted by the Legislature of the state of Utah:
             27          Section 1. Section 26-18-2.4 is amended to read:
             28           26-18-2.4. Medicaid drug program.
             29          (1) A Medicaid drug program developed by the department under Subsection 26-18-2.3

             30      (2)(f):
             31          (a) shall, notwithstanding Subsection 26-18-2.3 (1)(b), be based on clinical and
             32      cost-related factors which include medical necessity as determined by a provider in accordance
             33      with administrative rules established by the Drug Utilization Review Board;
             34          (b) may include therapeutic categories of drugs that may be exempted from the drug
             35      program;
             36          (c) may include placing some drugs, except [psychotropic or anti-psychotic drugs] the
             37      drugs described in Subsection (3), on a preferred drug list to the extent determined appropriate
             38      by the department; and
             39          (d) (i) except as prohibited by Subsections 58-17b-606 (4) and (5), shall permit a health
             40      care provider with prescriptive authority to override the restrictions of a preferred drug list
             41      provided that the medical necessity for the override is documented in the patient's medical file
             42      and by handwriting on the prescription "medically necessary - dispense as written"; and
             43          (ii) shall not permit a health care provider with prescriptive authority to override the
             44      restrictions of a preferred drug list with any preprinted instructions for dispense as written, or
             45      no substitutions allowed.
             46          (2) If the department implements a drug program under the provisions of Subsection
             47      (1)(c), the department shall:
             48          (a) determine the percentage of prescriptions that are paid for by the department which
             49      are overrides to the preferred drug list under Subsection (1)(d)(i);
             50          (b) include the information required by Subsection (2)(a) in the report required by
             51      Subsection (2)(c); and
             52          (c) report its findings regarding the drug program to the Legislative Health and Human
             53      Services Interim Committee by August 30, 2008, and to the Legislative Health and Human
             54      Services Appropriations Subcommittee during the 2009 General Session.
             55          (3) (a) For purposes of this Subsection (3), "immunosuppresssive drug":
             56          (i) means a drug that is used in immunosuppressive therapy to inhibit or prevent activity
             57      of the immune system to aid the body in preventing the rejection of transplanted organs and

             58      tissue; and
             59          (ii) does not include drugs used for the treatment of autoimmune disease or diseases
             60      that are most likely of autoimmune origin.
             61          (b) A preferred drug list developed under the provisions of this section may not include:
             62          (i) a psychotropic or anti-psychotic drug; or
             63          (ii) an immunosuppressive drug.
             64          (c) The state Medicaid program shall reimburse for a prescription for an
             65      immunosuppressive drug as written by the health care provider for a patient who has undergone
             66      an organ transplant. For purposes of Subsection 58-17b-606 (4), and with respect to patients
             67      who have undergone an organ transplant, the prescription for a particular immunosuppressive
             68      drug as written by a health care provider meets the criteria of demonstrating to the Department
             69      of Health a medical necessity for dispensing the prescribed immunosuppressive drug.
             70          (d) Notwithstanding the requirements of Part 2, Drug Utilization Review Board, the
             71      state Medicaid drug program may not require the use of step therapy for immunosuppressive
             72      drugs without the written or oral consent of the health care provider and the patient.

[Bill Documents][Bills Directory]